Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Part 1 results of a phase I/II study.
Haematologica. 2024 Feb 15. doi: 10.3324/haematol.2023.284347. Online ahead of print.
Haematologica. 2024.
PMID: 38356458
Free article.
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.
Ntanasis-Stathopoulos I, Filippatos C, Gavriatopoulou M, Malandrakis P, Eleutherakis-Papaiakovou E, Spiliopoulou V, Syrigou RE, Theodorakakou F, Fotiou D, Migkou M, Roussou M, Kastritis E, Dimopoulos MA, Terpos E.
Ntanasis-Stathopoulos I, et al. Among authors: syrigou re.
Diseases. 2023 Sep 18;11(3):123. doi: 10.3390/diseases11030123.
Diseases. 2023.
PMID: 37754319
Free PMC article.
Item in Clipboard
Cite
Cite